Tilray Stock Rises As Cannabis Giant Raises EBITDA Outlook, Targets Restructuring Across Canada
Tilray raises FY2027 EBITDA guidance to $70M-$75M and restructures Canadian cannabis operations, targeting $10M in annual savings.
Share
Why It Matters
Tilray says it will make more money by 2027 than it thought before. The company is also reorganizing to save money each year.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.